Topics

Yposkesi doubles manufacturing footprint to meet AAVs growing demand

05:05 EST 14 Jan 2020 | Outsourcing-Pharma

Yposkesi CDMO announces expansion to cover growing demand, strikes a deal on viral vectors production for a gene therapy development project.

Original Article: Yposkesi doubles manufacturing footprint to meet AAVs growing demand

NEXT ARTICLE

More From BioPortfolio on "Yposkesi doubles manufacturing footprint to meet AAVs growing demand"

Quick Search

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...